Brandyn D. Lau

Brandyn D. Lau

Auto-generated profile, based on publicly available information

Brandyn D. Lau

Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, USA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2018 in JAMA Surgery
Verified
Journal Article
Open access
PDF file
JCJoseph K. Canner
Joseph K. Canner
OHOmar Harfouch
Omar Harfouch
LKLisa M. Kodadek
Lisa M. Kodadek
DPDanielle Pelaez
Danielle Pelaez
DCDevin Coon
Devin Coon
BLBrandyn D. Lau
Brandyn D. Lau
Transgender individuals have a gender identity that differs from their sex at the time of birth.1,2 To address this incongruence, many transgender patients may seek gender-affirming interventions to achieve concordance between self-identified gender, physical appearance, and function. Gender-affirming interventions may include hormone therapy and gender-affirming surgical procedures such as genital or breast surgery and facial contouring.3,4 These interventions have been gaining attention from third-party payers in the past few years because health insurance coverage for transgender individuals has been shown to be both affordable and cost-effective.5 State and federal regulations have shifted toward ensuring coverage of gender-affirming care, with Section 1557 of the Affordable Care Act most recently banning discrimination on the basis of gender identity, while private insurers are also expanding coverage to include gender-affirming care.6

1 January 2015 in Medical Care
Verified
Journal Article
Closed access
BLBrandyn D. Mph Lau
Brandyn D. Mph Lau
AHAdil H. Haider
Adil H. Haider
MSMichael B. Streiff
Michael B. Streiff
CLChristoph U. Lehmann
Christoph U. Lehmann
PKPeggy S. PharmD Kraus
Peggy S. PharmD Kraus
EHElliott R. Haut
Elliott R. Haut
Background: All hospitalized patients should be assessed for venous thromboembolism (VTE) risk factors and prescribed appropriate prophylaxis. To improve best-practice VTE prophylaxis prescription for all hospitalized patients, we implemented a mandatory computerized clinical decision support (CCDS) tool. The tool requires completion of checklists to evaluate VTE risk factors and contraindications to pharmacological prophylaxis, and then recommends the risk-appropriate VTE prophylaxis regimen. Objectives: The objective of the study was to examine the effect of a quality improvement intervention on race-based and sex-based health care disparities across 2 distinct clinical services. Research Design: This was a retrospective cohort study of a quality improvement intervention. Subjects: The study included 1942 hospitalized medical patients and 1599 hospitalized adult trauma patients. Measures: In this study, the proportion of patients prescribed risk-appropriate, best-practice VTE prophylaxis was evaluated. Results: Racial disparities existed in prescription of best-practice VTE prophylaxis in the preimplementation period between black and white patients on both the trauma (70.1% vs. 56.6%, P=0.025) and medicine (69.5% vs. 61.7%, P=0.015) services. After implementation of the CCDS tool, compliance improved for all patients, and disparities in best-practice prophylaxis prescription between black and white patients were eliminated on both services: trauma (84.5% vs. 85.5%, P=0.99) and medicine (91.8% vs. 88.0%, P=0.082). Similar findings were noted for sex disparities in the trauma cohort. Conclusions: Despite the fact that risk-appropriate prophylaxis should be prescribed equally to all hospitalized patients regardless of race and sex, practice varied widely before our quality improvement intervention. Our CCDS tool eliminated racial disparities in VTE prophylaxis prescription across 2 distinct clinical services. Health information technology approaches to care standardization are effective to eliminate health care disparities.

20 March 2018 in Circulation
Verified
Journal Article
Closed access
BLBrandyn D. Lau
Brandyn D. Lau
MSMichael B. Streiff
Michael B. Streiff
PPPeter J. Pronovost
Peter J. Pronovost
EHElliott R. Haut
Elliott R. Haut
Venous thromboembolism (VTE) is 1 of the most common causes of preventable harm for patients in hospitals. Consequently, the Joint Commission, the Centers for Medicare and Medicaid Services, the Agency for Healthcare Research and Quality, the United Kingdom Care Quality Commission, the Australian Commission on Safety and Quality in Health Care, the Maryland Health Services Cost Review Commission, and the American College of Surgeons have prioritized measuring and reporting VTE outcomes with the goal of reducing the incidence of and preventable harm from VTE. We developed a rubric for defect-free VTE prevention, graded each organizational VTE quality measure, and found that none of the current VTE-related quality measures adequately characterizes VTE prevention efforts or outcomes in hospitalized patients. Effective VTE prevention is multifactorial: clinicians must assess patients’ risk for VTE and prescribe therapy appropriate for each patient’s risk profile, patients must accept the prescribed therapy, and nurses must administer the therapy as prescribed. First, an ideal, defect-free VTE prevention process measure requires: (1) documentation of a standardized VTE risk assessment; (2) prescription of optimal, risk-appropriate VTE prophylaxis; and (3) administration of all risk-appropriate VTE prophylaxis as prescribed. Second, an ideal VTE outcome measure should define potentially preventable VTE as VTE that developed in patients who experienced any VTE prevention process failures.

2 November 2018 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
EHElliott R. Haut
Elliott R. Haut
JAJonathan K. Aboagye
Jonathan K. Aboagye
DSDauryne L. Shaffer
Dauryne L. Shaffer
JWJiangxia Wang
Jiangxia Wang
DHDeborah B. Hobson
Deborah B. Hobson
BLBrandyn D. Lau
Brandyn D. Lau
Venous thromboembolism (VTE) remains a leading cause of preventable morbidity and mortality among hospitalized patients1-4 and poses an immense economic burden.5,6 Numerous successful interventions have been implemented in hospitals around the world to improve prescription of appropriate VTE prophylaxis.7,8 However, a substantial proportion of prescribed VTE prophylaxis doses are not administered.9-14 The leading cause of nonadministration of VTE prophylaxis medication is patient refusal,9,10 the causes of which have been explored through quantitative and qualitative studies.15,16

1 August 2017 in Journal of Critical Care
Verified
Journal Article
Closed access
DHDeborah B. Hobson
Deborah B. Hobson
TCTracy Y. Chang
Tracy Y. Chang
JAJonathan K. Aboagye
Jonathan K. Aboagye
BLBrandyn D. Lau
Brandyn D. Lau
HSHasan M. Shihab
Hasan M. Shihab
EHElliott R. Haut
Elliott R. Haut

1 December 2016 in Annals of Surgery
Verified
Journal Article
Closed access
BLBrandyn D. Mph Lau
Brandyn D. Mph Lau
GAGeorge J. Arnaoutakis
George J. Arnaoutakis
MSMichael B. Md Streiff
Michael B. Md Streiff
IHIsaac W. Howley
Isaac W. Howley
KPKatherine E. Poruk
Katherine E. Poruk
EHElliott R. MD Haut
Elliott R. MD Haut
Objective: To investigate the effect of providing personal clinical effectiveness performance feedback to general surgery residents regarding prescription of appropriate venous thromboembolism (VTE) prophylaxis. Background: Residents are frequently charged with prescribing medications for patients, including VTE prophylaxis, but rarely receive individual performance feedback regarding these practice habits. Methods: This prospective cohort study at the Johns Hopkins Hospital compared outcomes across 3 study periods: (1) baseline, (2) scorecard alone, and (3) scorecard plus coaching. All general surgery residents (n = 49) and surgical patients (n = 2420) for whom residents wrote admission orders during the first 9 months of the 2013–2014 academic year were included. Outcomes included the proportions of patients prescribed appropriate VTE prophylaxis, patients with preventable VTE, and residents prescribing appropriate VTE prophylaxis for every patient, and results from the Accreditation Council for Graduate Medical Education resident survey. Results: At baseline, 89.4% of patients were prescribed appropriate VTE prophylaxis and only 45% of residents prescribed appropriate prophylaxis for every patient. During the scorecard period, appropriate VTE prophylaxis prescription significantly increased to 95.4% (P < 0.001). For the scorecard plus coaching period, significantly more residents prescribed appropriate prophylaxis for every patient (78% vs 45%, P = 0.0017). Preventable VTE was eliminated in both intervention periods (0% vs 0.35%, P = 0.046). After providing feedback, significantly more residents reported receiving data about practice habits on the Accreditation Council for Graduate Medical Education resident survey (87% vs 38%, P < 0.001). Conclusions: Providing personal clinical effectiveness feedback including data and peer-to-peer coaching improves resident performance, and results in a significant reduction in harm for patients.